| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Smith & Nephew plc (NYSE: SNN)
SNN Technical Analysis
2
| As on 9th Jun 2023 SNN SHARE Price closed @ 30.08 and we RECOMMEND Buy for LONG-TERM with Stoploss of 29.21 & Strong Sell for SHORT-TERM with Stoploss of 33.99 we also expect STOCK to react on Following IMPORTANT LEVELS. |
SNNSHARE Price
| Open | 30.00 | Change | Price | % |
| High | 30.15 | 1 Day | -0.19 | -0.63 |
| Low | 29.95 | 1 Week | 0.18 | 0.60 |
| Close | 30.08 | 1 Month | -2.27 | -7.02 |
| Volume | 482500 | 1 Year | -3.23 | -9.70 |
| 52 Week High 36.38 | 52 Week Low 22.08 | ||||
NYSE USA Most Active Stocks
| DDR | 15.44 | -4.46% |
| NIO | 7.73 | -0.77% |
| TWTR | 53.70 | 0.66% |
| CVNA | 19.07 | -21.30% |
| BACA-U | 302.00 | 0.67% |
| PLTR | 15.02 | -1.12% |
| F | 13.74 | 1.18% |
| CS | 0.89 | 1.14% |
| RPAI | 13.15 | -3.17% |
| AUY | 5.85 | -0.68% |
NYSE USA Top Gainers Stocks
NYSE USA Top Losers Stocks
| SNN Daily Charts |
SNN Intraday Charts |
Whats New @ Bazaartrend |
SNN Free Analysis |
|
|
SNN Important Levels Intraday
| RESISTANCE | 30.47 |
| RESISTANCE | 30.34 |
| RESISTANCE | 30.27 |
| RESISTANCE | 30.19 |
| SUPPORT | 29.97 |
| SUPPORT | 29.89 |
| SUPPORT | 29.82 |
| SUPPORT | 29.69 |
SNN Forecast April 2024
| 4th UP Forecast | 38.87 |
| 3rd UP Forecast | 36.05 |
| 2nd UP Forecast | 34.31 |
| 1st UP Forecast | 32.57 |
| 1st DOWN Forecast | 27.59 |
| 2nd DOWN Forecast | 25.85 |
| 3rd DOWN Forecast | 24.11 |
| 4th DOWN Forecast | 21.29 |
SNN Weekly Forecast
| 4th UP Forecast | 33.38 |
| 3rd UP Forecast | 32.32 |
| 2nd UP Forecast | 31.67 |
| 1st UP Forecast | 31.01 |
| 1st DOWN Forecast | 29.15 |
| 2nd DOWN Forecast | 28.49 |
| 3rd DOWN Forecast | 27.84 |
| 4th DOWN Forecast | 26.78 |
SNN Forecast2024
| 4th UP Forecast | 58.75 |
| 3rd UP Forecast | 49.56 |
| 2nd UP Forecast | 43.87 |
| 1st UP Forecast | 38.19 |
| 1st DOWN Forecast | 21.97 |
| 2nd DOWN Forecast | 16.29 |
| 3rd DOWN Forecast | 10.6 |
| 4th DOWN Forecast | 1.41 |
Smith & Nephew plc ( NYSE USA Symbol : SNN )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
SNN Business Profile
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. The company was founded in 1856 and is headquartered in Watford, the United Kingdom. Address: Building 5, Watford, United Kingdom, WD18 8YE
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service